Expert Recommendation: Contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD)

José A. Alda, César Soutullo, Josep A. Ramos-Quiroga, Javier Quintero, Amaia Hervás, Isabel Hernández-Otero, Anna Sans-Fitó, Esther Cardo-Jalón, Alberto Fernández-Jaén, Maximino Fernández-Pérez, Ma Inés Hidalgo-Vieario, Lefa S. Eddy-Ives, Javier Sánchez

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Expert Recommendation: Contributions to clinical practice of the new prodrug lisdexamfetamine dimesylate (LDX) in the treatment of attention deficit hyperactivity disorder (ADHD)'. Together they form a unique fingerprint.

Medicine and Dentistry